Since PLOD2 has been reported to be positively regulated by PI3K-AKT signaling pathway activation in cancer cells [10], we used western blotting to evaluate P-AKT and P-Smad3 expression in PC12 cells. The gene discussed is SMAD3; the disease is cancer.